Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000434372 | SCV000525258 | likely pathogenic | not provided | 2016-02-29 | criteria provided, single submitter | clinical testing | A novel H524Y variant that is likely pathogenic was identified in the OCRL gene. It has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. H524Y is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position within the 5-phosphatase region that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (S522R, D523N/Y/G, P526S/T/L) have been reported in the Human Gene Mutation Database in association with OCRL-related disorders (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. |
Ce |
RCV000434372 | SCV000893002 | likely pathogenic | not provided | 2018-06-01 | criteria provided, single submitter | clinical testing |